Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma
Author(s) -
Menglong Zhang,
Weiguo Lai,
Jian Zhang,
Bijuan Hu,
Liyin Huang,
Cunkun Chu
Publication year - 2022
Publication title -
disease markers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 66
eISSN - 1875-8630
pISSN - 0278-0240
DOI - 10.1155/2022/6957580
Subject(s) - lenvatinib , hepatocellular carcinoma , medicine , liver cancer , stage (stratigraphy) , gastroenterology , survival rate , oncology , carcinoma , sorafenib , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom